Types of hypersensitivity reaction

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Reading File
I now have comprehensive content from multiple authoritative sources. Let me compile the full answer.

Types of Hypersensitivity Reactions (Gell and Coombs Classification)

Hypersensitivity is defined as an exaggerated or augmented immune response that is harmful to the host. It requires a presensitized state - reactions typically occur after the second encounter with a specific antigen (allergen). In 1963, Coombs and Gell classified hypersensitivity into four types (I-IV), later modified by Janeway et al. (2001). A fifth type and an innate category have since been added.
Six categories of hypersensitivity - Types I through V and Innate hypersensitivity
Figure: Six categories of hypersensitivity (Roitt's Essential Immunology)

Type I - Immediate (IgE-Mediated) Hypersensitivity

FeatureDetail
MediatorIgE antibody
Cells involvedMast cells, basophils, eosinophils
OnsetWithin seconds to minutes of re-exposure
MechanismAntigen cross-links cell-bound IgE on mast cells → degranulation → release of pharmacologically active mediators
Mediators released:
  • Primary (preformed): Histamine - causes vasodilation, increased capillary permeability, bronchospasm
  • Secondary (newly formed): Prostaglandins and leukotrienes (derived from arachidonic acid): LTB4 (chemoattractant), LTC4 and LTD4 (vasodilation, vascular permeability), TNF-alpha, IL-4
Clinical examples:
  • Systemic anaphylaxis (e.g., after penicillin, bee sting)
  • Allergic asthma
  • Allergic rhinitis / hay fever
  • Urticaria and angioedema
  • Atopic eczema, food allergy
Atopy: A subgroup with strong familial predisposition, elevated IgE levels, and classic presentations (hay fever, asthma, eczema).
Treatment: Epinephrine (first-line for anaphylaxis), antihistamines, corticosteroids; avoidance of the allergen.

Type II - Antibody-Dependent Cytotoxic Hypersensitivity

FeatureDetail
MediatorIgG (or IgM) antibodies
TargetCell surface or extracellular matrix antigens
OnsetHours
MechanismAntibody binds cell-surface antigen → complement activation → cell lysis via MAC, opsonization for phagocytosis, or ADCC by NK cells
Clinical examples:
  • Hemolytic anemia (autoimmune or drug-induced, e.g., penicillin-coated RBCs)
  • ABO blood transfusion reactions
  • Rh hemolytic disease of the newborn
  • Goodpasture syndrome (anti-GBM antibody - kidney and lung basement membranes)
  • Myasthenia gravis (antibodies to acetylcholine receptors - but note: blocking, not stimulating, so some classify as a variant)
Note: When antibodies stimulate rather than destroy (as in Graves' disease), this is now sometimes classified separately as Type V.

Type III - Immune Complex-Mediated Hypersensitivity

FeatureDetail
MediatorIgG antibodies complexed with soluble antigen
Onset6-12 hours (Arthus); days-weeks (serum sickness)
MechanismPersistent antigen-antibody complexes are deposited in tissues → complement activation → neutrophil/macrophage recruitment → inflammation and tissue damage
Two main forms:
  1. Arthus reaction (local): Low-dose antigen injected into skin → IgG + complement + mast cell/neutrophil mediators → local necrotic reaction within 12 hours
  2. Serum sickness (systemic): Large amount of foreign protein/antigen → circulating immune complexes deposited in joints, kidneys, blood vessels
Clinical examples:
  • Post-streptococcal glomerulonephritis (lumpy IgG + C3 deposits along GBM on immunofluorescence)
  • Serum sickness
  • Vasculitis
  • Subacute bacterial endocarditis
  • Systemic lupus erythematosus (lupus nephritis)
  • Rheumatoid arthritis (joint deposition)
  • Hypersensitivity pneumonitis (farmer's lung - fungal spore antigens)

Type IV - Cell-Mediated (Delayed-Type) Hypersensitivity

FeatureDetail
MediatorSensitized T cells (no antibody involved)
Onset48-72 hours (hence "delayed")
MechanismAntigen-presenting cells activate sensitized T cells → T cell proliferation, cytokine release (IFN-gamma, IL-2) → macrophage activation, inflammation, tissue damage
T cell subtypes involved (Janeway's modification):
SubtypeEffectorExample
Th1Macrophage activationTuberculin reaction, contact dermatitis
Th2Eosinophil activationChronic allergic asthma
Th17Neutrophil/macrophage activationRheumatoid arthritis, atopic dermatitis
Cytotoxic T cellsDirect cell killingPoison ivy, graft rejection, viral-infected cell killing
Clinical examples:
  • Tuberculin (Mantoux) test - classic example
  • Contact dermatitis (nickel, poison ivy, poison oak, topical drugs)
  • Granulomatous diseases (tuberculosis, leprosy, sarcoidosis)
  • Graft rejection
  • Some forms of eczema

Type V - Stimulatory Hypersensitivity (added to the original classification)

FeatureDetail
MediatorIgG antibody acting as a receptor agonist
MechanismAntibody binds a cell surface receptor and mimics the normal ligand, continuously stimulating the cell (no cytotoxicity)
Clinical example:
  • Graves' disease: Anti-TSH receptor antibody acts as a TSH agonist, constitutively stimulating the thyroid → hyperthyroidism. Unlike TSH, the antibody is not subject to negative feedback, so stimulation is continuous.
  • Agonistic autoantibodies to angiotensin II AT1 receptor in preeclampsia and hypertension.

Innate Hypersensitivity (additional category)

Excessive activation of pattern recognition receptors (PRRs) (e.g., TLRs) on innate cells by PAMPs such as LPS leads to massive cytokine release (TNF, IL-1beta, IL-6) - causing toxic shock, ARDS, and DIC, as seen in Gram-negative sepsis. Superantigens from Staphylococcus/Streptococcus directly cross-link T-cell receptors and provoke massive cytokine release (toxic shock syndrome) via a related mechanism.

Quick Comparison Summary

TypeNameAntibody/CellOnsetClassic Example
IImmediate / AnaphylacticIgEMinutesAnaphylaxis, asthma, hay fever
IICytotoxicIgG/IgM vs. cell surfaceHoursTransfusion reaction, Goodpasture
IIIImmune complexIgG + soluble Ag6-12 h / daysPost-strep GN, serum sickness, SLE
IVDelayed / Cell-mediatedT cells (no Ab)48-72 hTuberculin test, contact dermatitis
VStimulatoryIgG agonist AbVariableGraves' disease
Innate-Innate PRR activationHoursGram-neg sepsis, toxic shock

Sources: Jawetz, Melnick & Adelberg's Medical Microbiology 28e; Goldman-Cecil Medicine; Roitt's Essential Immunology; Janeway's Immunobiology 10e

Pathogenesis of gas gangrene

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Loading Image
Excellent - I now have comprehensive content from multiple authoritative sources. Let me compile the full detailed answer.

Pathogenesis of Gas Gangrene (Clostridial Myonecrosis)

Causative Organisms

Gas gangrene is caused by histotoxic Clostridium species - anaerobic, Gram-positive, spore-bearing bacilli:
  • C. perfringens (type A) - responsible for ~90% of cases; the dominant pathogen
  • C. novyi and C. septicum - next most common; C. septicum notably causes spontaneous gas gangrene without an obvious wound (associated with colonic malignancy)
  • C. histolyticum, C. bifermentans (less common)
These organisms are widely found in soil and feces. Spores may originate from the patient's own intestinal flora or from the environment.

Predisposing Conditions (Enabling Pathogenesis)

For infection to develop, three conditions must coexist:
  1. Wound contamination with spores - from soil, clothing, dirt, or bowel flora
  2. Devitalized (avascular/necrotic) tissue - provides the anaerobic, low redox potential microenvironment essential for spore germination and bacterial multiplication
  3. Significant delay between injury and surgical management - allowing time for bacterial proliferation and toxin production
Classic settings:
  • High-velocity gunshot or shrapnel wounds (wartime) - cavitation sucks in foreign material, leaving devascularized tissue
  • Compound fractures, crush injuries
  • Limb ischemia (peripheral vascular disease, diabetics)
  • Postoperative wounds, especially bowel surgery
  • Septic/incomplete abortions (C. perfringens infects retained necrotic products of conception)
  • Spontaneous gas gangrene - bacteremia from a GI source (especially C. septicum) seeds muscle, without any external wound

Step-by-Step Pathogenesis

Step 1 - Spore Germination
Spores deposited in devitalized tissue encounter a critically low oxidation-reduction (redox) potential. This anaerobic environment triggers germination of spores into actively metabolizing vegetative bacteria.
Step 2 - Rapid Bacterial Multiplication
Vegetative clostridia multiply rapidly. Their fermentative metabolism produces CO₂ and H₂ gas (from carbohydrate and protein breakdown), which accumulates in the tissues - the hallmark that gives the disease its name. This gas production further lowers tissue oxygen tension, creating a self-perpetuating cycle that favors continued anaerobic growth.
Step 3 - Toxin Production (the key pathogenic step)
C. perfringens produces at least 12 exotoxins, classified by four major toxin types (alpha, beta, epsilon, theta). The most pathogenically important are:
ToxinTypeMechanismEffect
Alpha-toxin (lecithinase, phospholipase C)Primary, majorHydrolyzes phosphatidylcholine in cell membranes; activates arachidonic acid pathwayDestroys muscle cell membranes, lyses RBCs (hemolysis), destroys platelets and PMNs, causes widespread capillary damage, leads to shock
Theta-toxin (perfringolysin O)Pore-forming cytolysinInserts into cholesterol-containing membranes, forming poresCytolysis of many cell types; contributes to tissue necrosis and vascular damage
Collagenase (kappa toxin)Collagen-splittingDegrades collagen in connective tissueFacilitates spread through tissue planes
Hyaluronidase (mu toxin)Spreading factorDegrades hyaluronic acidAllows spread through connective tissue matrix
Other proteasesVariousDegrade structural proteinsFurther tissue destruction
Alpha-toxin is the master toxin - it is the major cause of both local tissue destruction and the systemic shock seen in gas gangrene. Fatal cases can occur without bacteremia, strongly suggesting that circulating alpha-toxin absorption drives the systemic effects.
Step 4 - Propagation of Necrosis and the "Leukocyte Block"
A cardinal and unique histological feature of gas gangrene is the near-complete absence of inflammatory cells (leukocytes) within necrotic tissue, despite accumulation of leukocytes in adjacent vessels. This occurs because:
  • Alpha-toxin and theta-toxin destroy PMNs directly
  • Toxins increase vascular permeability, causing massive edema that impairs leukocyte migration
  • Platelet aggregation and microvascular occlusion further impair tissue perfusion
This "leukocyte block" means the host cannot mount an effective local inflammatory defense, allowing unimpeded bacterial spread. The infection progresses along muscle bundles at a rate of up to 10 cm per hour.
Histopathology of gas gangrene - widespread muscle necrosis with paucity of leukocytes in infected tissue (arrows indicate leukocyte accumulation in adjacent vessels)
Histopathology of experimental C. perfringens gas gangrene showing widespread muscle necrosis, absence of leukocytes in necrotic tissue, and accumulation in adjacent vessels (arrows) - Harrison's Principles of Internal Medicine 22e
Step 5 - Systemic Effects and Shock
As infection spreads, alpha-toxin is systemically absorbed:
  • Intravascular hemolysis - RBC destruction releases hemoglobin → jaundice, hemoglobinuria
  • Increased vascular permeability → massive edema and fluid sequestration
  • Hypotension and circulatory collapse (shock)
  • Renal failure (from hemoglobinuria + hypoperfusion)
  • Coma and death - often within 48 hours if untreated
Remarkably, patients remain alert and lucid until very late stages of shock.

Clinical Correlation of Pathogenesis

FeaturePathogenic Basis
Severe pain (earliest symptom)Edema under pressure, toxin-mediated tissue damage
Tense, shiny skin; pallorMassive edema from increased vascular permeability (alpha-toxin)
Crepitus (gas in tissue)CO₂ + H₂ from bacterial fermentation - a late sign
Thin, brown, sweet/musty-smelling exudateMuscle/protein breakdown products
Hemorrhagic bullae, discolorationVascular damage, hemolysis
Paucity of pusLeukocyte destruction by alpha and theta toxins
Rapid systemic deteriorationCirculating alpha-toxin → hemolysis, shock, organ failure
Clinical appearance of gas gangrene - massive edema, discoloration and hemorrhagic bullae of the forearm
Clinical appearance of gas gangrene: massive edema, purple-gray discoloration, and skin breakdown - Sherris & Ryan's Medical Microbiology 8e

Spontaneous Gas Gangrene (Special Variant)

Caused primarily by C. septicum, which is more aerotolerant. It occurs without any external wound - the organism enters the bloodstream from a GI source (often a colonic carcinoma or neutropenic enterocolitis) and seeds damaged or ischemic muscle. Bacteremia typically precedes cutaneous manifestations by several hours, so blood cultures are critical when this is suspected.

Key Pathogenesis Summary

Spore contamination of devitalized wound
           ↓
Low redox potential → Spore germination → Vegetative multiplication
           ↓
Gas production (CO₂, H₂) → Anaerobic environment maintained
           ↓
Alpha-toxin (lecithinase) + Theta-toxin production
           ↓
Cell membrane destruction → Myonecrosis + Hemolysis + PMN lysis
           ↓
Collagenase + Hyaluronidase → Spread along tissue planes (up to 10 cm/h)
           ↓
Leukocyte block → No local defense → Unimpeded spread
           ↓
Systemic alpha-toxin absorption → Shock → Renal failure → Death

Sources: Harrison's Principles of Internal Medicine 22e; Sherris & Ryan's Medical Microbiology 8e; Bailey & Love's Short Practice of Surgery 28e; Campbell's Operative Orthopaedics 15e (2026); Pye's Surgical Handicraft 22e
This is a shared conversation. Sign in to Orris to start your own chat.